CXCR4 and B-cell chronic lymphocytic leukemia: Importantly, combining CAR T‐cell treatment with interleukin‐10 (IL‐10) or CXCR4 blockade effectively improved cytotoxicity against CLL cells, even in stromal‐protected regions within the 3D model.